Additional file 1 of Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study
Creators: name: Liqing Ning
name: Chuanyu Hu
name: Pingfan Lu
name: Yimei Que
name: Zhu, Xiaojian
name: Dengju Li
Publisher: name: figshare
Year: 2020
Subjects: subject: Medicine
subject: Biotechnology
subject: Immunology
subject: FOS: Clinical medicine
subject: FOS: Clinical medicine
subject: Cancer
subject: Science Policy
subject: Hematology
subject: Computational Biology

description: Additional file 1: Table S1.Top 10 countries or territories with most incidence, death or DALYs cases in 2017. Table S2. Top 10 countries or territories with highest age-standardized rate of incidence, deaths, or DALYs in 2017. Table S3 .Top 5 countries or territories with the most increase and decrease in age-standardized rate of incidence, deaths, or DALYs from 1990 to 2017. Figure S1. The global EAPCs of CML in 195 countries or territories in 2017: a The EAPCs of incidence in 2017; b the EAPCs of deaths in 2017; c the EAPCs of DALYs in 2017. CML, chronic myeloid leukemia; DALYs, disability-adjusted life years; EAPCs estimated annual percentage changes. Figure S2. The incidence, death, and DALY rates of CML in different age groups: a The incidence rate in 1990; b The incidence rate in 2017; c The death rate in 1990; d The death rate in 2017; e The DALYs rate in 1990; f The DALYs rate in 2017. CML, chronic myeloid leukemia; DALYs, disability-adjusted life years. Figure S3 .The death cases of CML in three age groups from 1990 to 2017: a The death cases in the globe; b The death cases in the high SDI regions; c The death cases in the high-middle SDI regions; d The death cases in the middle SDI regions; e The death cases in the low-middle SDI regions; f The death cases in the low SDI regions. The three age groups included 15–49 years, 50–69 years, and 70+ years. SDI, socio-demographic index. Figure S4 .The DALYs of CML in three age groups from 1990 to 2017: a The DALYs in the globe; b The DALYs in the high SDI regions; c The DALYs in the high-middle SDI regions; d The DALYs in the middle SDI regions; e The DALYs in the low-middle SDI regions; f The DALYs in the low SDI regions. The three age groups included 15–49 years, 50–69 years, and 70+ years. SDI, socio-demographic index; DALYs, disability-adjusted life years. Figure S5. The proportion of different ages and sex in CML incidence cases (a) and death cases (b), and DALYs (c) from 1990 to 2017. DALYs, disability-adjusted life years. Figure S6. The age-standardized rates of CML DALYs attributed to risk factors from 1990 to 2017 in Global (a), High SDI (b), High-middle SDI (c), Middle SDI (d), Low-middle SDI (e), Low SDI (f). CML, chronic myeloid leukemia; SDI, socio-demographic index. DALYs, disability-adjusted life years. Figure S7. The percent of CML deaths attributed to risk factors from 1990 to 2017 in Global (a), High SDI (b), High-middle SDI (c), Middle SDI (d), Low-middle SDI (e), Low SDI (f). CML, chronic myeloid leukemia; SDI, socio-demographic index. Figure S8 .The percent of CML DALYs attributed to risk factors from 1990 to 2017 in Global (a), High SDI (b), High-middle SDI (c), Middle SDI (d), Low-middle SDI (e), Low SDI (f). CML, chronic myeloid leukemia; SDI, socio-demographic index. DALYs, disability-adjusted life years